Drug Approval | June 12, 2022
Strides receives USFDA approval for Ibuprofen OTC oral suspension
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
To address the preventive & primary healthcare delivery gaps in India
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Subscribe To Our Newsletter & Stay Updated
